1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
• 1.2.1 Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Bioanalysis and DMPK Studies

1.2.3 Toxicology Testing

1.2.4 Safety Pharmacology

1.2.5 Others

1.3 Market by Application

1.3.1 Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Small and Medium Pharmaceutical Company

1.3.3 Large Pharmaceutical Company

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Pharmaceutical Development Preclinical CRO Market Perspective (2017-2028)
• 2.2 Pharmaceutical Development Preclinical CRO Growth Trends by Region
• 2.2.1 Pharmaceutical Development Preclinical CRO Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Pharmaceutical Development Preclinical CRO Historic Market Size by Region (2017-2022)

2.2.3 Pharmaceutical Development Preclinical CRO Forecasted Market Size by Region (2023-2028)

2.3 Pharmaceutical Development Preclinical CRO Market Dynamics

2.3.1 Pharmaceutical Development Preclinical CRO Industry Trends

2.3.2 Pharmaceutical Development Preclinical CRO Market Drivers

2.3.3 Pharmaceutical Development Preclinical CRO Market Challenges

2.3.4 Pharmaceutical Development Preclinical CRO Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmaceutical Development Preclinical CRO Players by Revenue
• 3.1.1 Global Top Pharmaceutical Development Preclinical CRO Players by Revenue (2017-2022)

3.1.2 Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Players (2017-2022)

3.2 Global Pharmaceutical Development Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharmaceutical Development Preclinical CRO Revenue

3.4 Global Pharmaceutical Development Preclinical CRO Market Concentration Ratio

3.4.1 Global Pharmaceutical Development Preclinical CRO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Development Preclinical CRO Revenue in 2021

3.5 Pharmaceutical Development Preclinical CRO Key Players Head office and Area Served

3.6 Key Players Pharmaceutical Development Preclinical CRO Product Solution and Service

3.7 Date of Enter into Pharmaceutical Development Preclinical CRO Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Development Preclinical CRO Breakdown Data by Type

• 4.1 Global Pharmaceutical Development Preclinical CRO Historic Market Size by Type (2017-2022)
• 4.2 Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Type (2023-2028)

5 Pharmaceutical Development Preclinical CRO Breakdown Data by Application

• 5.1 Global Pharmaceutical Development Preclinical CRO Historic Market Size by Application (2017-2022)
• 5.2 Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Pharmaceutical Development Preclinical CRO Market Size (2017-2028)
• 6.2 North America Pharmaceutical Development Preclinical CRO Market Size by Type
• 6.2.1 North America Pharmaceutical Development Preclinical CRO Market Size by Type (2017-2022)

6.2.2 North America Pharmaceutical Development Preclinical CRO Market Size by Type (2023-2028)

6.2.3 North America Pharmaceutical Development Preclinical CRO Market Share by Type (2017-2028)

6.3 North America Pharmaceutical Development Preclinical CRO Market Size by Application

6.3.1 North America Pharmaceutical Development Preclinical CRO Market Size by Application (2017-2022)

6.3.2 North America Pharmaceutical Development Preclinical CRO Market Size by Application (2023-2028)

6.3.3 North America Pharmaceutical Development Preclinical CRO Market Share by Application (2017-2028)

6.4 North America Pharmaceutical Development Preclinical CRO Market Size by Country

6.4.1 North America Pharmaceutical Development Preclinical CRO Market Size by Country (2017-2022)

6.4.2 North America Pharmaceutical Development Preclinical CRO Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

• 7.1 Europe Pharmaceutical Development Preclinical CRO Market Size (2017-2028)
• 7.2 Europe Pharmaceutical Development Preclinical CRO Market Size by Type
• 7.2.1 Europe Pharmaceutical Development Preclinical CRO Market Size by Type (2017-2022)

7.2.2 Europe Pharmaceutical Development Preclinical CRO Market Size by Type (2023-2028)

7.2.3 Europe Pharmaceutical Development Preclinical CRO Market Share by Type (2017-2028)

7.3 Europe Pharmaceutical Development Preclinical CRO Market Size by Application

7.3.1 Europe Pharmaceutical Development Preclinical CRO Market Size by Application (2017-2022)

7.3.2 Europe Pharmaceutical Development Preclinical CRO Market Size by Application (2023-2028)

7.3.3 Europe Pharmaceutical Development Preclinical CRO Market Share by Application (2017-2028)

7.4 Europe Pharmaceutical Development Preclinical CRO Market Size by Country

7.4.1 Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2017-2022)

7.4.2 Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size (2017-2028)
• 8.2 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Type
• 8.2.1 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Share by Type (2017-2028)

8.3 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Application

8.3.1 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Share by Application (2017-2028)

8.4 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region

8.4.1 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

• 9.1 Latin America Pharmaceutical Development Preclinical CRO Market Size (2017-2028)
• 9.2 Latin America Pharmaceutical Development Preclinical CRO Market Size by Type
• 9.2.1 Latin America Pharmaceutical Development Preclinical CRO Market Size by Type (2017-2022)

9.2.2 Latin America Pharmaceutical Development Preclinical CRO Market Size by Type (2023-2028)

9.2.3 Latin America Pharmaceutical Development Preclinical CRO Market Share by Type (2017-2028)

9.3 Latin America Pharmaceutical Development Preclinical CRO Market Size by Application

9.3.1 Latin America Pharmaceutical Development Preclinical CRO Market Size by Application (2017-2022)

9.3.2 Latin America Pharmaceutical Development Preclinical CRO Market Size by Application (2023-2028)

9.3.3 Latin America Pharmaceutical Development Preclinical CRO Market Share by Application (2017-2028)

9.4 Latin America Pharmaceutical Development Preclinical CRO Market Size by Country

9.4.1 Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2017-2022)

9.4.2 Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size (2017-2028)
• 10.2 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Type
• 10.2.1 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Share by Type (2017-2028)

10.3 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Application

10.3.1 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Share by Application (2017-2028)

10.4 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country

10.4.1 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

• 11.1 Charles River
• 11.1.1 Charles River Company Details

11.1.2 Charles River Business Overview

11.1.3 Charles River Pharmaceutical Development Preclinical CRO Introduction

11.1.4 Charles River Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.1.5 Charles River Recent Developments

11.2 Wuxi AppTec

11.2.1 Wuxi AppTec Company Details

11.2.2 Wuxi AppTec Business Overview

11.2.3 Wuxi AppTec Pharmaceutical Development Preclinical CRO Introduction

11.2.4 Wuxi AppTec Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.2.5 Wuxi AppTec Recent Developments

11.3 Labcorp

11.3.1 Labcorp Company Details

11.3.2 Labcorp Business Overview

11.3.3 Labcorp Pharmaceutical Development Preclinical CRO Introduction

11.3.4 Labcorp Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.3.5 Labcorp Recent Developments

11.4 Eurofins Scientific

11.4.1 Eurofins Scientific Company Details

11.4.2 Eurofins Scientific Business Overview

11.4.3 Eurofins Scientific Pharmaceutical Development Preclinical CRO Introduction

11.4.4 Eurofins Scientific Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.4.5 Eurofins Scientific Recent Developments

11.5 PPD, Inc.

11.5.1 PPD, Inc. Company Details

11.5.2 PPD, Inc. Business Overview

11.5.3 PPD, Inc. Pharmaceutical Development Preclinical CRO Introduction

11.5.4 PPD, Inc. Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.5.5 PPD, Inc. Recent Developments

11.6 ICON Plc.

11.6.1 ICON Plc. Company Details

11.6.2 ICON Plc. Business Overview

11.6.3 ICON Plc. Pharmaceutical Development Preclinical CRO Introduction

11.6.4 ICON Plc. Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.6.5 ICON Plc. Recent Developments

11.7 Pharmaron

11.7.1 Pharmaron Company Details

11.7.2 Pharmaron Business Overview

11.7.3 Pharmaron Pharmaceutical Development Preclinical CRO Introduction

11.7.4 Pharmaron Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.7.5 Pharmaron Recent Developments

11.8 Inotiv

11.8.1 Inotiv Company Details

11.8.2 Inotiv Business Overview

11.8.3 Inotiv Pharmaceutical Development Preclinical CRO Introduction

11.8.4 Inotiv Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.8.5 Inotiv Recent Developments

11.9 ChemPartner

11.9.1 ChemPartner Company Details

11.9.2 ChemPartner Business Overview

11.9.3 ChemPartner Pharmaceutical Development Preclinical CRO Introduction

11.9.4 ChemPartner Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.9.5 ChemPartner Recent Developments

11.10 JOINN Lab

11.10.1 JOINN Lab Company Details

11.10.2 JOINN Lab Business Overview

11.10.3 JOINN Lab Pharmaceutical Development Preclinical CRO Introduction

11.10.4 JOINN Lab Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.10.5 JOINN Lab Recent Developments

11.11 EVOTEC

11.11.1 EVOTEC Company Details

11.11.2 EVOTEC Business Overview

11.11.3 EVOTEC Pharmaceutical Development Preclinical CRO Introduction

11.11.4 EVOTEC Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.11.5 EVOTEC Recent Developments

11.12 Medicilon

11.12.1 Medicilon Company Details

11.12.2 Medicilon Business Overview

11.12.3 Medicilon Pharmaceutical Development Preclinical CRO Introduction

11.12.4 Medicilon Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.12.5 Medicilon Recent Developments

11.13 Crown Bioscience

11.13.1 Crown Bioscience Company Details

11.13.2 Crown Bioscience Business Overview

11.13.3 Crown Bioscience Pharmaceutical Development Preclinical CRO Introduction

11.13.4 Crown Bioscience Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.13.5 Crown Bioscience Recent Developments

11.14 Champion Oncology

11.14.1 Champion Oncology Company Details

11.14.2 Champion Oncology Business Overview

11.14.3 Champion Oncology Pharmaceutical Development Preclinical CRO Introduction

11.14.4 Champion Oncology Revenue in Pharmaceutical Development Preclinical CRO Business (2017-2022)

11.14.5 Champion Oncology Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
• 13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

Market Analysis and Insights: Global Pharmaceutical Development Preclinical CRO Market
The global Pharmaceutical Development Preclinical CRO market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Bioanalysis and DMPK Studies accounting for % of the Pharmaceutical Development Preclinical CRO global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Small and Medium Pharmaceutical Company segment is altered to an % CAGR throughout this forecast period.

China Pharmaceutical Development Preclinical CRO market size is valued at US$ million in 2021, while the North America and Europe Pharmaceutical Development Preclinical CRO are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pharmaceutical Development Preclinical CRO landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Development Preclinical CRO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Development Preclinical CRO market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Development Preclinical CRO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Development Preclinical CRO market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Pharmaceutical Development Preclinical CRO market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Pharmaceutical Development Preclinical CRO Breakdown Data by Type

Bioanalysis and DMPK Studies

Toxicology Testing

Safety Pharmacology

Others

Pharmaceutical Development Preclinical CRO Breakdown Data by Application

Small and Medium Pharmaceutical Company

Large Pharmaceutical Company

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Charles River

Wuxi AppTec

Labcorp

Eurofins Scientific

PPD, Inc.

ICON Plc.

Pharmaron

Inotiv

ChemPartner

JOINN Lab

EVOTEC

Medicilon

Crown Bioscience

Champion Oncology

Frequently Asked Questions

What factors will challenge the Pharmaceutical Development Preclinical CRO market growth?

Which end-use segment will expand at the fastest CAGR in the Pharmaceutical Development Preclinical CRO market?

Which are the emerging players in the Pharmaceutical Development Preclinical CRO market?

How concentrated is the Pharmaceutical Development Preclinical CRO market?

Which factors are positively contributing to the Pharmaceutical Development Preclinical CRO market growth?

Which are the novel product innovations in the Pharmaceutical Development Preclinical CRO market?

Which product segment will emerge as the most lucrative in the Pharmaceutical Development Preclinical CRO market?

Which factors are increasing the competition in the Pharmaceutical Development Preclinical CRO market?

Which are the strategic measures taken by the Pharmaceutical Development Preclinical CRO industry players?

Which region will witness inactive growth during the forecast period?

What key trends are likely to emerge in the Pharmaceutical Development Preclinical CRO market in the coming years?